Pyxis Oncology Inc.
(PYXS)
undefined
undefined%
At close: undefined
1.62
-0.55%
Pre-market Dec 16, 2024, 04:01 AM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts,
total investments, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Cash & Equivalents | 9.66M | 179.29M | 274.74M | 8.08M | 19.69M |
| Short-Term Investments | 109.63M | - | - | - | - |
| Long-Term Investments | - | - | - | - | - |
| Other Long-Term Assets | - | - | 109.00K | 109.00K | 30.00K |
| Receivables | 21.00K | 598.00K | - | - | - |
| Inventory | - | 874.00K | - | - | - |
| Other Current Assets | 5.29M | 6.72M | 3.94M | 23.00K | 11.00K |
| Total Current Assets | 124.60M | 186.61M | 278.67M | 8.10M | 19.70M |
| Property-Plant & Equipment | 24.81M | 24.77M | 1.24M | 1.94M | 76.00K |
| Goodwill & Intangibles | 24.31M | - | - | - | - |
| Total Long-Term Assets | 49.12M | 24.77M | 1.35M | 2.05M | 106.00K |
| Total Assets | 173.73M | 211.38M | 280.02M | 10.15M | 19.81M |
| Account Payables | 3.90M | 7.10M | 11.95M | 1.08M | 491.00K |
| Deferred Revenue | 7.66M | - | 6.33M | 1.95M | 224.00K |
| Short-Term Debt | 2.46M | - | 330.00K | 615.00K | 9.00K |
| Other Current Liabilities | 11.74M | 24.54M | 6.43M | 1.93M | 124.00K |
| Total Current Liabilities | 25.76M | 31.63M | 18.71M | 3.69M | 733.00K |
| Long-Term Debt | 20.10M | 18.92M | - | 165.00K | 6.00K |
| Other Long-Term Liabilities | - | - | - | 21.94M | 21.94M |
| Total Long-Term Liabilities | 22.26M | 18.92M | - | 22.11M | 21.95M |
| Total Liabilities | 48.02M | 50.55M | 18.71M | 25.80M | 22.68M |
| Total Debt | 21.33M | 18.92M | 165.00K | 780.00K | 15.00K |
| Common Stock | 45.00K | 34.00K | 32.00K | 1K | 1K |
| Retained Earnings | -286.23M | -212.44M | -91.72M | -15.74M | -2.92M |
| Comprehensive Income | 63.00K | - | -280.02M | -21.94M | -21.94M |
| Shareholders Equity | 125.70M | 160.82M | 261.31M | -15.64M | -2.87M |
| Total Investments | 109.63M | - | - | - | - |